HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Comparison of the cytotoxic effects of enantiopure PPAPs, including nemorosone and clusianone.

Abstract
The synthesis of an unnatural polyprenylated acylphloroglucinol (PPAP), regioisomeric with nemorosone and clusianone, has been accomplished. The separated enantiomers of this new PPAP, along with those of nemorosone and clusianone, have been screened for activity against HeLa (cervix carcinoma), MIA-PaCa-2 (pancreatic carcinoma), and MCF7 (mamma carcinoma) cancer cell lines. All of the isomers examined gave surprisingly similar results in the screens.
AuthorsNigel S Simpkins, Frank Holtrup, Vincent Rodeschini, James D Taylor, Robert Wolf
JournalBioorganic & medicinal chemistry letters (Bioorg Med Chem Lett) Vol. 22 Issue 19 Pg. 6144-7 (Oct 01 2012) ISSN: 1464-3405 [Electronic] England
PMID22944119 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2012 Elsevier Ltd. All rights reserved.
Chemical References
  • 7-epiclusianone
  • Antineoplastic Agents
  • Benzophenones
  • Benzoquinones
  • Bridged Bicyclo Compounds
  • nemorosone
Topics
  • Antineoplastic Agents (chemical synthesis, chemistry, pharmacology)
  • Benzophenones (chemical synthesis, chemistry, pharmacology)
  • Benzoquinones
  • Bridged Bicyclo Compounds (chemical synthesis, chemistry, pharmacology)
  • Cell Line, Tumor
  • Dose-Response Relationship, Drug
  • Drug Screening Assays, Antitumor
  • HeLa Cells
  • Humans
  • MCF-7 Cells
  • Molecular Conformation
  • Stereoisomerism
  • Structure-Activity Relationship

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: